Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Weiye Li MD, PhD
Weiye Li MD, PhD Advisory Board
Paul Freeman OD, FAAO, FOVDR
Paul B. Freeman OD, FAAO, FOVDR Editor-in-Chief
Leonard Press OD, FAAO, FCOVD
Leonard J. Press OD, FAAO, FCOVD Associate Editor
See All Experts
featured
Published in Eye Care

Journal Scan / Research · August 09, 2018

Comparison of Panretinal Photocoagulation and Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

JAMA Ophthalmology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Adam Glassman MS

JAMA Ophthalmology
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
JAMA Ophthalmol 2018 Jul 24;[EPub Ahead of Print], JG Gross, AR Glassman, D Liu, JK Sun, AN Antoszyk, CW Baker, NM Bressler, MJ Elman, FL Ferris, TW Gardner, LM Jampol, DF Martin, M Melia, CR Stockdale, RW Beck

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated